Type 2 diabetes (T2D) and obesity (OB) are associated with chronic low-grade inflammation and increased fracture risk. In vitro studies showed that inflammation induces bone erosion and inhibits bone ...
Since signalling by TNFα and IL-1β is not exclusively mediated by the endosomal pathway, inhibition by HCQ is most likely incomplete and the effects of HCQ, for example, on signalling by TNFα will be ...
Belgian biopharma company UCB is bringing up the rear of the IL-17 inhibitor category with its bimekizumab drug, so is celebrating new late-stage data showing superiority to the class leader.
This study presents important findings on the role of CXXC-finger protein 1 in regulatory T cell gene regulation and function. The evidence supporting the authors' claims is solid, with mostly ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...
belle.shiga-med.ac.jp Background and aim: Interleukin (IL) 17 is a cytokine which exerts strong proinflammatory activities. In this study we evaluated changes in IL-17 expression in the inflamed ...
Here’s how it works. That final phone may steal much of the attention, but it’s the iPhone 17 Pro Max that will probably have the most impressive specs. And while we’re not expecting it to ...
Emmanuel Caeymaex, Executive Vice President and Chief Commercial Officer, UCB, called the FDA’s decision a “milestone” for the company in its mission to address unmet needs across a range of IL-17 ...